Dalal RS, Cabral HJ, Carlin A, Ilse MP, et al. Outcomes After Dose Intensification of Risankizumab for Crohn's Disease. Clin Gastroenterol Hepatol 2024 Dec 9:S1542-3565(24)01067.
PMID: 39662691